Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting

Go back to Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
TELEFLEX INCORPORATED (NYSE: TFX) Delayed: 130.40 -0.75 (0.57%)
Previous Close $131.15    52 Week High $188.79 
Open $130.61    52 Week Low $125.28 
Day High $132.21    P/E 37.69 
Day Low $129.41    EPS $3.46 
Volume 400,451